FDA Oncology (@fdaoncology) 's Twitter Profile
FDA Oncology

@fdaoncology

FDA Oncology Center of Excellence expedites medical product development to improve the lives of people with cancer.

ID: 836298809605046278

linkhttp://www.fda.gov/OCE calendar_today27-02-2017 19:35:48

8,8K Tweet

39,39K Takipçi

353 Takip Edilen

FDA Oncology (@fdaoncology) 's Twitter Profile Photo
FDA Oncology
@fdaoncology

4 years ago

FDA granted accelerated approval to infigratinib (Truseltiq, QED Therapeutics), a kinase inhibitor for adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with an FGFR2 fusion or other rearrangement #OCENewsBurst bit.ly/3yOjvRA